Albert Koong
@ackoongmdphd.bsky.social
Physician-scientist, radiation oncologist, cancer biologist.
Division Head and Chair, Radiation Oncology, MD Anderson Cancer Center
#radonc #endcancer
https://scholar.google.com/citations?user=6k_0CuQAAAAJ&hl=en
Division Head and Chair, Radiation Oncology, MD Anderson Cancer Center
#radonc #endcancer
https://scholar.google.com/citations?user=6k_0CuQAAAAJ&hl=en
Inhibition of ATR and PKMYT1 induces synthetic lethality in RB1-deficient #BreastCancer. Important implications for pts resistant to CDK4/6 inhibitors. @mdanderson.bsky.social #EndCancer
www.science.org/doi/10.1126/...
www.science.org/doi/10.1126/...
Rb1 deficiency induces synthetic lethality with ATR and PKMYT1 coinhibition in breast cancer cell lines and patient-derived xenografts
ATR/PKMYT1 coinhibition induces synthetic lethality in Rb1-deficient breast cancers, supporting biomarker-guided therapy.
www.science.org
January 2, 2026 at 2:21 PM
Inhibition of ATR and PKMYT1 induces synthetic lethality in RB1-deficient #BreastCancer. Important implications for pts resistant to CDK4/6 inhibitors. @mdanderson.bsky.social #EndCancer
www.science.org/doi/10.1126/...
www.science.org/doi/10.1126/...
Reposted by Albert Koong
Researchers at MD Anderson discovered a promising therapeutic pathway for a challenging subtype of acute myeloid leukemia that uses a combination of therapies.
Read more: spr.ly/63320CeB4E #OncSky #EndCancer
Read more: spr.ly/63320CeB4E #OncSky #EndCancer
December 29, 2025 at 7:22 PM
Researchers at MD Anderson discovered a promising therapeutic pathway for a challenging subtype of acute myeloid leukemia that uses a combination of therapies.
Read more: spr.ly/63320CeB4E #OncSky #EndCancer
Read more: spr.ly/63320CeB4E #OncSky #EndCancer
Radiation induces cell death through copper overload suggesting new therapeutic strategies for cancer pts. #radonc #endancer #cuproptosis @mdanderson.bsky.social
www.cell.com/cancer-cell/...
www.sciencedirect.com/science/arti...
www.cell.com/cancer-cell/...
www.sciencedirect.com/science/arti...
www.cell.com
December 21, 2025 at 2:43 PM
Radiation induces cell death through copper overload suggesting new therapeutic strategies for cancer pts. #radonc #endancer #cuproptosis @mdanderson.bsky.social
www.cell.com/cancer-cell/...
www.sciencedirect.com/science/arti...
www.cell.com/cancer-cell/...
www.sciencedirect.com/science/arti...
Annual holiday ornament exchange for the @MDAnderson.bsky.social Division Heads. May the holiday season bring everyone joy and peace. #endcancer
December 19, 2025 at 12:43 AM
Annual holiday ornament exchange for the @MDAnderson.bsky.social Division Heads. May the holiday season bring everyone joy and peace. #endcancer
Reposted by Albert Koong
How do you improve cancer care without reinventing the wheel?
A first-of-its-kind journal launched at MD Anderson is helping teams share real-world education and quality improvement projects with clinicians around the world. Read more. spr.ly/63327CuOx1 #OncSky #EndCancer
A first-of-its-kind journal launched at MD Anderson is helping teams share real-world education and quality improvement projects with clinicians around the world. Read more. spr.ly/63327CuOx1 #OncSky #EndCancer
Journal launch enables oncology education and quality improvement
An interest in process improvement projects and learning from others led radiation oncologist Shalin Shah, M.D., to help launch MD Anderson’s first academic journal, Advances in Cancer Education and Quality Improvement (ACE-QI).
spr.ly
December 18, 2025 at 3:08 PM
How do you improve cancer care without reinventing the wheel?
A first-of-its-kind journal launched at MD Anderson is helping teams share real-world education and quality improvement projects with clinicians around the world. Read more. spr.ly/63327CuOx1 #OncSky #EndCancer
A first-of-its-kind journal launched at MD Anderson is helping teams share real-world education and quality improvement projects with clinicians around the world. Read more. spr.ly/63327CuOx1 #OncSky #EndCancer
I always enjoy getting together with this group of #radonc leaders @mdanderson.bsky.social. #endcancer
December 4, 2025 at 12:01 PM
I always enjoy getting together with this group of #radonc leaders @mdanderson.bsky.social. #endcancer
What an inspiring day to walk with our patients, colleagues, and supporters. @mdanderson.bsky.social Boot Walk to #EndCancer. Still have time to contribute #OnlyPossibleHere
mdanderson.donordrive.com/participants...
mdanderson.donordrive.com/participants...
November 15, 2025 at 10:22 PM
What an inspiring day to walk with our patients, colleagues, and supporters. @mdanderson.bsky.social Boot Walk to #EndCancer. Still have time to contribute #OnlyPossibleHere
mdanderson.donordrive.com/participants...
mdanderson.donordrive.com/participants...
November 13, 2025 at 1:52 AM
Any guesses regarding where is this location?
November 1, 2025 at 4:10 PM
Any guesses regarding where is this location?
Parents weekend at Brown University!
October 18, 2025 at 1:58 PM
Parents weekend at Brown University!
Excited to share our review of metabolic cell death pathways relevant for cancer therapy. @mdanderson.bsky.social #endcancer
rdcu.be/eK7vV
rdcu.be/eK7vV
Exploiting metabolic cell death for cancer therapy
Nature Reviews Cancer - In this Review, Mao et al. discuss the regulation and interplay of the metabolic cell death pathways ferroptosis, disulfidptosis and cuproptosis and explore how these...
rdcu.be
October 15, 2025 at 3:32 PM
Excited to share our review of metabolic cell death pathways relevant for cancer therapy. @mdanderson.bsky.social #endcancer
rdcu.be/eK7vV
rdcu.be/eK7vV
October 8, 2025 at 11:19 PM
Reposted by Albert Koong
📢 Excited to share our new pub @JCO_ASCO
ascopubs.org/doi/10.1200/...
✅We report late colorectal cancer dose-response models for colorectum RT dose and chemo
#radonc #medphys #survivorship
@MDAndersonNews
ascopubs.org/doi/10.1200/...
✅We report late colorectal cancer dose-response models for colorectum RT dose and chemo
#radonc #medphys #survivorship
@MDAndersonNews
October 4, 2025 at 1:30 PM
📢 Excited to share our new pub @JCO_ASCO
ascopubs.org/doi/10.1200/...
✅We report late colorectal cancer dose-response models for colorectum RT dose and chemo
#radonc #medphys #survivorship
@MDAndersonNews
ascopubs.org/doi/10.1200/...
✅We report late colorectal cancer dose-response models for colorectum RT dose and chemo
#radonc #medphys #survivorship
@MDAndersonNews
That's a wrap! Another #ASTRO25 in the books. Great catching up with everyone. See you in Boston for #ASTRO26! #radonc #endcancer @mdanderson.bsky.social
October 2, 2025 at 9:24 PM
That's a wrap! Another #ASTRO25 in the books. Great catching up with everyone. See you in Boston for #ASTRO26! #radonc #endcancer @mdanderson.bsky.social
October 1, 2025 at 12:31 AM
Reposted by Albert Koong
"MD Anderson is committed to extending our reach to improve cancer care globally," says @schmeler.bsky.social during her #ASTRO25 presentation on identifying international partners when setting up a global oncology program.
Learn more: spr.ly/6013A5Rzf #EndCancer
Learn more: spr.ly/6013A5Rzf #EndCancer
Global Outreach
If you are ready to make an appointment, select a button on the right. If you have questions about MD Anderson's appointment process, our information page may be the best place to start.
spr.ly
September 29, 2025 at 1:11 AM
"MD Anderson is committed to extending our reach to improve cancer care globally," says @schmeler.bsky.social during her #ASTRO25 presentation on identifying international partners when setting up a global oncology program.
Learn more: spr.ly/6013A5Rzf #EndCancer
Learn more: spr.ly/6013A5Rzf #EndCancer
At #ASTRO25, MD Anderson experts will present findings from the latest research into radiation oncology.
Learn more: spr.ly/63320Adeji @ackoongmdphd.bsky.social #EndCancer
Learn more: spr.ly/63320Adeji @ackoongmdphd.bsky.social #EndCancer
Top 4 MD Anderson abstracts at ASTRO 2025
At the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting, MD Anderson investigators will share new research that may shape the future of radiation oncology. Highlights include long-term data supporting non-surgical treatment options, advances in personalized pain relief and imaging innovations that could make care more precise.
spr.ly
September 26, 2025 at 11:29 PM
Reposted by Albert Koong
"Without this network of mentorship and institutional support, I would not be in the position I am today as a physician-scientist leading my own laboratory," says our Dr. Vincent Bernard-Pagan.
His insights from radiation oncology training: spr.ly/63325AbA5H #OncSky #EndCancer
His insights from radiation oncology training: spr.ly/63325AbA5H #OncSky #EndCancer
4 things I learned from my radiation oncology training at MD Anderson
After completing his radiation oncology residency at MD Anderson and joining the faculty, Vincent Bernard-Pagan, M.D., Ph.D., shares what he learned from his training and what sets MD Anderson apart for trainees.
spr.ly
September 25, 2025 at 8:00 PM
"Without this network of mentorship and institutional support, I would not be in the position I am today as a physician-scientist leading my own laboratory," says our Dr. Vincent Bernard-Pagan.
His insights from radiation oncology training: spr.ly/63325AbA5H #OncSky #EndCancer
His insights from radiation oncology training: spr.ly/63325AbA5H #OncSky #EndCancer
Reposted by Albert Koong
Targeted radiation gave patients with oligometastatic kidney cancer a median of nearly 3 years without systemic therapy while maintaining high survival. A ctDNA biomarker may help personalize this approach. spr.ly/63320ADVdQ #OncSky #EndCancer
Targeted radiation helps patients with kidney cancer delay systemic therapy
Targeted radiation helps patients with kidney cancer delay systemic therapy
spr.ly
September 5, 2025 at 7:00 PM
Targeted radiation gave patients with oligometastatic kidney cancer a median of nearly 3 years without systemic therapy while maintaining high survival. A ctDNA biomarker may help personalize this approach. spr.ly/63320ADVdQ #OncSky #EndCancer
Congrats to these @MDAnderson.bsky.social #radonc faculty for their achievements in these areas. Amazing work to #endcancer!
August 15, 2025 at 1:20 AM
Congrats to these @MDAnderson.bsky.social #radonc faculty for their achievements in these areas. Amazing work to #endcancer!
Congrats to Dr. Prajnan Das for this recognition. This is one of the highest honors bestowed upon @mdanderson.bsky.social faculty. #endcancer #radonc
August 14, 2025 at 10:47 PM
Congrats to Dr. Prajnan Das for this recognition. This is one of the highest honors bestowed upon @mdanderson.bsky.social faculty. #endcancer #radonc
Most recent ranking of scientific journals from Google scholar.
scholar.google.com/citations?vi...
scholar.google.com/citations?vi...
scholar.google.com
August 8, 2025 at 12:00 PM
Most recent ranking of scientific journals from Google scholar.
scholar.google.com/citations?vi...
scholar.google.com/citations?vi...
Thrilled to announce that after a highly competitive national search, Dr. Prajnan Das has been selected as the inaugural chair of GIRO Department @mdanderson.bsky.social . Looking forward to all the great things he will do in this new role. #rad onc #endcancer
June 30, 2025 at 8:34 PM
Thrilled to announce that after a highly competitive national search, Dr. Prajnan Das has been selected as the inaugural chair of GIRO Department @mdanderson.bsky.social . Looking forward to all the great things he will do in this new role. #rad onc #endcancer